Busulfan is a carcinostatic which is used for myelocytic leukemia. A 42-yea
r-old Japanese woman given high doses of busulfan for a short time was refe
rred to us because of decreased visual acuity and blurred vision in both ey
es. She received 212 mg/day of busulfan for only 4 days. Ophthalmoscopic ex
amination demonstrated a posterior polar subcapsular opacity of the lens in
both eyes. Although the occurrence of cataract due to busulfan has been re
ported after long-term administration of busulfan, this is the first clinic
al case of cataract caused by high doses of busulfan for a short period. It
is necessary to pay more attention to busulfan cataract. Copyright (C) 199
9 S. Karger AG, Basel.